A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2011
12/01/2011	WO2011148941A1 Sugar responsive gel and medicine administering device
12/01/2011	WO2011148640A1 Blood flow promoter and external preparation
12/01/2011	WO2011148253A2 Solid dosage forms of antipsychotics
12/01/2011	WO2011148243A1 Extended release formulation of pramipexole
12/01/2011	WO2011148209A2 New use of diatomaceous earth in the pharmaceutical industry
12/01/2011	WO2011148207A1 Procedure for biphasic preparation of liposomes and application thereof in manufacturing diagnostic reagents
12/01/2011	WO2011148135A1 Translocation across eukaryotic cell membranes based on oomycete protein sequence motifs
12/01/2011	WO2011148014A1 Use of oxaloacetate in the treatment of ischaemia
12/01/2011	WO2011147926A2 Magnetically responsive membrane structures
12/01/2011	WO2011147921A1 Stable multi-dose compositions comprising an antibody and a preservative
12/01/2011	WO2011147536A2 Topical pharmaceutical compositions
12/01/2011	WO2011147471A1 Antidementia oral pharmaceutical solutions
12/01/2011	WO2011147281A1 Aqueous formulation of vitamins and preparation method thereof
12/01/2011	WO2011147280A1 Injection of enrofloxacin and producing method thereof
12/01/2011	WO2011147231A1 Medicinal composition for treating leukemia, preparing method and use thereof
12/01/2011	WO2011147185A1 Immunosuppressant j2 - sodium alginate microsphere, preparation method and use thereof
12/01/2011	WO2011147025A1 Controlled release dosage form comprising quetiapine
12/01/2011	WO2011126385A3 Assay system
12/01/2011	WO2011126352A3 Anti-tuberculosis preparation based on an inclusion complex of cyclodextrin with rifampicin and a method for the preparation thereof
12/01/2011	WO2011124739A4 Silica nanoparticles for the intracellular diffusion of poorly soluble bioactive agents
12/01/2011	WO2011121475A3 Modified release dosage form comprising desvenlafaxine or salts thereof
12/01/2011	WO2011119059A4 Photo-crosslinked gellan gum-based hydrogels: preparation methods and uses thereof
12/01/2011	WO2011115700A3 Emollient foams for treatment of seborrheic dermatitis
12/01/2011	WO2011115489A3 Spray-pumpable composition suitable for topical skin application
12/01/2011	WO2011090306A3 Liquid formulations for long-acting erythropoietin conjugate
12/01/2011	WO2011085356A3 Povidone-iodine and sucrose wound healing dressing
12/01/2011	WO2011081443A3 Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof
12/01/2011	WO2011079279A3 Nanoconjugates and nanoconjugate formulations
12/01/2011	WO2011077406A3 Process for preparing tablets comprising 5- hydroxytryptophan and tryptophan
12/01/2011	WO2011076843A3 Combination therapy for copd
12/01/2011	WO2011076842A3 Aerosol formulation for copd
12/01/2011	WO2011076840A3 Aerosol formulation for copd
12/01/2011	WO2011067672A3 Arranging interaction and back pressure chambers for microfluidization
12/01/2011	WO2011058449A3 Ophthalmic preparations based on bdnf (brain-derived neurotrophic factor) and their use
12/01/2011	WO2011049713A3 Stabilized glucagon solutions
12/01/2011	WO2011035335A3 Stabilized liquid and lyophilized adamts13 formulations
12/01/2011	WO2011034604A3 Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof
12/01/2011	WO2011023194A3 New compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine
12/01/2011	WO2011016043A3 Antibiotic drug delivery and potentiation
12/01/2011	WO2010146551A3 Orally disintegrating compositions comprising antihypertensive agents
12/01/2011	WO2010133609A3 Composition comprising oil drops
12/01/2011	WO2010105842A9 Preparation for external application
12/01/2011	WO2010067199A8 Mixtures of plants in spagyric mother tincture for dry cough in babies
12/01/2011	US20110295341 Medication delivery system and monitor
12/01/2011	US20110295241 Method and apparatus for improving local hypoxicity for enhanced therapy
12/01/2011	US20110295190 Wound Dressing and Methods of Making and Using the Same
12/01/2011	US20110295151 Enteroendocrine Manipulation for Metabolic Effect
12/01/2011	US20110294981 Chimeric t1r taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric t1r polypeptides
12/01/2011	US20110294902 Pharmaceutical compositions providing enhanced drug concentrations
12/01/2011	US20110294889 Infusion and Injection Solution of Levodopa
12/01/2011	US20110294880 Pharmaceutical composition containing prostaglandin
12/01/2011	US20110294759 Once daily formulations of tetracyclines
12/01/2011	US20110293733 Self-assembling nanoparticle drug delivery system
12/01/2011	US20110293732 Nanoparticles made of amorphous cellulose
12/01/2011	US20110293731 Loading of hydrophobic drugs into hydrophilic polymer delivery systems
12/01/2011	US20110293730 Polylactide nanoparticles
12/01/2011	US20110293729 Novel composition based on gamma-hydroxybutyric acid
12/01/2011	US20110293728 Photosensitizer-metal nanoparticle complex and composition containing the complex for photodynamic therapy or diagnosis
12/01/2011	US20110293727 Chimeric therapeutics, compositions, and methods for using same
12/01/2011	US20110293726 Chimeric therapeutics, compositions, and methods for using same
12/01/2011	US20110293725 Chimeric therapeutics, compositions, and methods for using same
12/01/2011	US20110293724 Enzyme Treatment of Foodstuffs for Celiac Sprue
12/01/2011	US20110293723 Synthetic nanocarrier combination vaccines
12/01/2011	US20110293722 Hydrogel sponges, methods of producing them and uses thereof
12/01/2011	US20110293721 Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith
12/01/2011	US20110293720 Progestin-containing drug delivery system
12/01/2011	US20110293719 Novel compounds and compositions and methods of use
12/01/2011	US20110293718 Compositions of R(+) and S(-) Pramipexole and Methods of Using the Same
12/01/2011	US20110293717 Compacted moxifloxacin
12/01/2011	US20110293716 Pharmaceutical formulation containing ibuprofen and codeine
12/01/2011	US20110293715 Pharmaceutical Formulation and Process for Its Preparation
12/01/2011	US20110293714 Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides
12/01/2011	US20110293713 Pharmaceutical formulations comprising nsaid and proton pump inhibitor drugs
12/01/2011	US20110293712 Coaxially encapsulated cell suspensions and microtissues
12/01/2011	US20110293711 Utilization of Dialkylfumarates
12/01/2011	US20110293710 Immunomodulatory properties of lactobacillus strains
12/01/2011	US20110293709 Peptide tyrosinase inhibitors and uses thereof
12/01/2011	US20110293708 Process for preparing purified nucleic acid and the use thereof
12/01/2011	US20110293707 Use of the cathelicidin ll-37 and derivatives thereof for wound healing
12/01/2011	US20110293706 Nanoshells on polymers
12/01/2011	US20110293705 Methods and compositions for localized agent delivery
12/01/2011	US20110293704 Priming of an immune response
12/01/2011	US20110293703 Aminoalcohol lipidoids and uses thereof
12/01/2011	US20110293702 Compounds and Methods for the Treatment of Inflammatory Diseases of the CNS
12/01/2011	US20110293701 Multivalent synthetic nanocarrier vaccines
12/01/2011	US20110293700 Nanocarrier compositions with uncoupled adjuvant
12/01/2011	US20110293699 Hydrogel implants with varying degrees of crosslinking
12/01/2011	US20110293698 Reagents and Methods for Treating Cancer
12/01/2011	US20110293697 HIV-1 Immunogenic Compositions
12/01/2011	US20110293696 Compositions and methods for treating bruises
12/01/2011	US20110293695 Amphoteric liposomes
12/01/2011	US20110293694 Quantum unit of inheritance vector therapy method
12/01/2011	US20110293693 Quantum unit of inheritance vector therapy
12/01/2011	US20110293692 Hydrogel implants with varying degrees of crosslinking
12/01/2011	US20110293691 Multimodal adhesion barrier
12/01/2011	US20110293690 Biodegradable Polymer Encapsulated Microsphere Particulate Film and Method of Making Thereof
12/01/2011	US20110293689 Immobilized biologically active entities having a high degree of biological activity
12/01/2011	US20110293688 Hydrogel implants with varying degrees of crosslinking
12/01/2011	US20110293687 Hydrogel implants with varying degrees of crosslinking
12/01/2011	US20110293686 Anti-viral compositions and methods for administration

1 ... 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 ... 2991